R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

The new year brought a slew of new faces in the pharma and biotech world, especially in the top jobs, with a number of CEO changes at biotech firms.

R&D

Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.

R&D

Learn how to foster growth for early-stage biotech companies through innovative ecosystem strategies and valuable CDMO collaborations

R&D

These new regulations for running clinical trials in the UK will be a legal requirement from 28th April 2026.

R&D

Organoid-based approaches may become an integral part of neurological safety testing, offering a clearer view of risk.

R&D

Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.